Anuh Pharma LimitedNSE: ANUHPHR

ANUHPHR: Q3 FY26 saw higher revenue, profit, and margins, plus a completed 1: 1 bonus share issue

· Issued by Anuh Pharma Limited

Revenue and net profit rose year-over-year in Q3 FY26, with improved EBITDA margins and EPS. A 1:1 bonus share issue was completed, and the company recognized incremental obligations due to new labour codes.

Original document:

This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.

Earlier from Anuh Pharma

All Anuh Pharma news releases